TRANSLUCENCY - Key Persons
Fiona has held senior management posts in the NHS and was a health visitor in community nursing, so she understands the difficulties and challenges the NHS faces in choosing where to invest in new products and services. She can use this experience to help you build a compelling business case for your product, then put it in front of the right people in the right way.
As managing director of Translucency, Mark makes the best-possible business case for your product in the UK market. And he's chosen the best people to do so in 14 other countries across Western Europe.
Mark's scientific, clinical, marketing and communication skills allow him to produce compelling, believable and easily understood deliverables to support your product. Blended with his deep market knowledge and extensive contact network in the health services, he'll make sure you reach the people you need to reach in the right way.
Where your interest is in more than one country, Mark's comprehensive evidence reviews underpin your business case in different countries, so we only have to do that work once. Translucency's local experts then build on this work to address coding, local applications, costs and reimbursement rates specific to each country.
Our MD has focused on evidence-based medicine throughout his career. He understands clinical needs and payer perspectives, as well as commercial aspirations.
Where your interest is in more than one country, Mark's comprehensive evidence reviews underpin your business case in different countries, so we only have to do that work once. Translucency's local experts then build on this work to address coding, local applications, costs and reimbursement rates specific to each country.
Our MD has focused on evidence-based medicine throughout his career. He understands clinical needs and payer perspectives, as well as commercial aspirations.
Mark first entered the healthcare system as a doctor (a family practitioner). But his interest in improving the efficiency and cost-effectiveness of healthcare led him to research clinical behaviour and its implications for guidelines and clinical audit.
He gained a PhD at Cardiff University, where he developed a new method of identifying groups in which health interventions are most cost-effective. Management now uses this method as an aid to decision-making.
Mark spent eight years as a senior medical manager in the NHS assessing health needs and the cost-effectiveness of new technologies and interventions. His experience managing budgets and planning means he understands exactly what key decision-makers need when they're assessing new products.
NICE (the National Institute for Health and Care Excellence) will be well-known to anyone looking to market a new healthcare product. Mark is uniquely familiar with the organisation: he was a founding member of NICE's forerunner, the Wessex Development and Evaluation Committee. He will navigate their processes and guidelines, helping you to create the best-possible evidence-based case for your product.
In fact, Mark's knowledge of NICE was vital for Sirtex. Tony Dixon, national sales manager at Sirtex, said: “We approached Mark to support market access and reimbursement issues in the UK, particularly around NICE's interventional procedures application process - which was very problematic for us at the time.
Martin will help you gain market access and reimbursement for your product in Spain, Portugal, and The Netherlands.
His experience of medical devices, medical technology and pharmaceutical products, plus his familiarity with market access and reimbursement planning in Spain and Portugal, gives him an edge when it comes to getting your business case seen and heard.
Martin's skills lie in business development, reimbursement and pricing, sales and marketing and regulatory affairs. But he also has a scientific background, holding a Master's Degree in Natural Sciences from the University of Cambridge, UK. His scientific knowledge enables him to use his business skills to the best advantage in healthcare settings.
And, as a fluent speaker of Spanish, Catalan and Portuguese, you can be sure nothing will be lost in translation.
A sound scientific background underpins Paula's strong business skills: she holds an MA in Natural Sciences and an MSc in Information Science. She is a Member of the Chartered Institute of Marketing and speaks regularly at conferences on medical device reimbursement.
Paula started work in the medical devices industry as group product manager at Amersham International (now part of GE Healthcare), where she launched a novel IVD (in-vitro diagnostic) platform. She moved on to become marketing director at Howmedica International, which made orthopaedic implants. And before she joined Translucency, Paula was director of operations at Quintiles Consulting, specialising in medical device reimbursement. So when it comes to getting the best results for your product, Paula has extensive experience and a successful track record.
With experience of a wide range of medical technologies, in-depth knowledge of the French healthcare system and a native French speaker, Robert will smooth your path into the French market.
His expertise will help you put together a funding and reimbursement strategy for France - and implement it effectively. He can help you lobby at technical structure level. And he can design clinical trials for your product and evaluate them in the context of French healthcare reimbursement.
Robert is skilled at navigating French healthcare systems, reducing the possibility of delays in securing reimbursement. He understands PMSI (the French classification system for hospital patient stays) in depth.
Robert holds a Doctorate in Medicine, a Degree in Sport Medicine and a Degree in Statistics applied to Biology. He also trained in hospital management at CNAM (Conservatoire National des Arts et MГ©tiers).
Thomas will use his in-depth knowledge of German, Austrian and Swiss healthcare systems to help you launch your product in these markets.
You can rely on his international experience in selling and marketing medical devices to get the best for your product in your target markets.
Thomas specialises in analysing the market and funding situation specific to your technology. He and Translucency can help you get the best possible reimbursement for your product in Germany, Austria and Switzerland.
He will work with you whatever stage you're at: if you're right at the start of your marketing process, Thomas will undertake customised reimbursement analyses and produce a roadmap for your product in German-speaking countries in Europe. He can ensure market access and implement the strategies you put together. Thomas will prepare and submit formal reimbursement applications, with comprehensive evidence analysis to demonstrate value and cost-effectiveness. And he'll develop all the support materials and tools you'll need, and teach you to use them, to get the best results for your product in Germany, Austria or Switzerland.
Job Titles:
- National Sales Manager at Sirtex
Job Titles:
- Associate
- Pharmacist
- Expert
Ulrich's expertise will help you through the Dutch healthcare system, a market with legally private entities acting within public law and in which a large proportion of hospital tariffs (DBCs) have negotiable pricing. He will also support you in emergency care and trauma care, which in contrast, are funded by fixed unit tariffs, by the Dutch healthcare Authority (NZa). He will be able to show you the relevance and importance of health technology assessment (HTA) and clinical guidelines in all sectors.
Ulrich is a qualified pharmacist and he has an MBA. He speaks on Dutch Healthcare finance and organisation at conferences and is a teacher in a university on Dutch Healthcare finance and organisation
Ulrich has held reimbursement and market access positions at Allergan, Roche and Boehringer Ingelheim.
Ulrich is available to support you through the reimbursement and pricing complexities of the Dutch market. If you want to launch your product in the Netherlands call us today.
Ulrich is our expert on market access and reimbursement in the Netherlands. His expertise in market access, pricing and reimbursement, health economics, budget impact and cost-effectiveness modelling will support you through the steps of commercialisation in the Netherlands.